Founded with a mission to transform biomedical data into actionable insights, Molecular Health develops software solutions designed for evidence-based healthcare decision support and smarter drug development. Their core offerings include advanced data curation and deep analytics tools that provide healthcare professionals and researchers with critical insights for improved patient outcomes and efficient drug discovery processes. The company focuses on leveraging human expertise combined with state-of-the-art technology to revolutionize the healthcare and pharmaceutical industries.

Molecular Health has formed notable partnerships, including a commercial agreement with Integrated DNA Technologies to integrate their variant annotation and reporting software with the Archer NGS research assay platform. This collaboration underscores their commitment to enhancing research capabilities and clinical decision-making. The company's innovative approach has positioned it as a key player in the healthcare technology sector, driving significant advancements in personalized medicine and drug development.